sNfL predicts NEDA-status in a 6-year longitudinal cohort of MS patients

sNfL predicts NEDA-status in a 6-year longitudinal cohort of MS patients

The predictive value of NEDA-3 for long-term disability in MSПодробнее

The predictive value of NEDA-3 for long-term disability in MS

sNfL identifies patients at higher risk of future disease activity beyond NEDA-3 statusПодробнее

sNfL identifies patients at higher risk of future disease activity beyond NEDA-3 status

NEDA-No Evidence of Disease ActivityПодробнее

NEDA-No Evidence of Disease Activity

Multiple Sclerosis Awareness MonthПодробнее

Multiple Sclerosis Awareness Month

Neural circuits for maternal sensitivity to infant vocalizations - Dr Silvana Valtcheva - NYU, USПодробнее

Neural circuits for maternal sensitivity to infant vocalizations - Dr Silvana Valtcheva - NYU, US

No evidence of disease activity as a predictive measure of long-term disability in RRMSПодробнее

No evidence of disease activity as a predictive measure of long-term disability in RRMS

sNfL as a predictor of 10-year gray matter atrophy and clinical disability in MSПодробнее

sNfL as a predictor of 10-year gray matter atrophy and clinical disability in MS

Evaluation of sNfL in MS patients with NEDA-3Подробнее

Evaluation of sNfL in MS patients with NEDA-3

No Evidence Of Disease Activity (NEDA): the goal of Multiple Sclerosis (MS) treatmentПодробнее

No Evidence Of Disease Activity (NEDA): the goal of Multiple Sclerosis (MS) treatment

Dr. Borghaei on 2-Year Findings With Nivolumab Vs Docetaxel in NSCLCПодробнее

Dr. Borghaei on 2-Year Findings With Nivolumab Vs Docetaxel in NSCLC

Early Oral Manifestations of Autoimmune Diseases in WomenПодробнее

Early Oral Manifestations of Autoimmune Diseases in Women

1112. Social Determinants of Health in Rare Neuroimmune DisordersПодробнее

1112. Social Determinants of Health in Rare Neuroimmune Disorders

COVID-19 Questions and Answers for Individuals Affected by Rare Neuroimmune Disorders — Part IIIПодробнее

COVID-19 Questions and Answers for Individuals Affected by Rare Neuroimmune Disorders — Part III

Dr. Sequist Discusses Adverse Events Associated With CO-1686Подробнее

Dr. Sequist Discusses Adverse Events Associated With CO-1686

Organizing the Neuro Exam: Mental Status and Cranial Nerves [UndergroundMed]Подробнее

Organizing the Neuro Exam: Mental Status and Cranial Nerves [UndergroundMed]

Newborn Screening Can Identify Disorders (4 min.)Подробнее

Newborn Screening Can Identify Disorders (4 min.)

Should We Predict Neurodevelopmental Disabilities Prior to Symptoms?Подробнее

Should We Predict Neurodevelopmental Disabilities Prior to Symptoms?

Health Check with Dr. NooristaniПодробнее

Health Check with Dr. Nooristani